SCHEMBL7039083

SCHEMBL7039083

C=CCc1c(O)ccc(C=O)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.43
ERN1 O75460 4/20 0.42
XDH P47989 1/20 0.38
ALDH1A1 P00352 3/20 0.37
GABRA1 P14867 2/20 0.37
GABRB2 P47870 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ALDH2 P05091 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
AKR1B1 P15121 1/20 0.37
HPGD P15428 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8518278 0.84 SRD5A1 (0.46) SRD5A1ERN1XDHALDH1A1GABRA1
SCHEMBL3957273 0.82 SRD5A1 (0.45) SRD5A1ERN1XDHALDH1A1GABRA1
SCHEMBL7194028 0.79 ERN1 (0.42) SRD5A1ERN1XDHALDH1A1GABRA1
SCHEMBL10639712 0.78 CYP3A4 (0.46) SRD5A1XDHALDH1A1GABRA1GABRB2
SCHEMBL7044769 0.76 ERN1 (0.42) ERN1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL28778162 0.76 SRD5A1 (0.40) SRD5A1ERN1XDHALDH1A1GABRA1
SCHEMBL22297592 0.76 ERN1 (0.38) SRD5A1ERN1ALDH1A1GABRA1GABRB2
SCHEMBL431551 0.75 ERN1 (0.52) SRD5A1ERN1XDHALDH1A1GABRA1
SCHEMBL323547 0.74 XDH (0.54) SRD5A1XDHALDH1A1GABRA1GABRB2
SCHEMBL219677 0.73 ERN1 (0.54) ERN1ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed